🏆Medical oncologist and researcher John Haanen has been awarded the prestigious 2024 ESMO Lifetime Achievement Award. This honor, presented by the ESMO - European Society for Medical Oncology, recognizes his exceptional contributions to the field of oncology. Haanen is being celebrated for his groundbreaking research in innovative immunotherapies, particularly tumor-infiltrating lymphocytes (TIL) therapies for metastatic melanoma. His work has had a significant impact on cancer treatment and offers hope to many patients worldwide. In addition to his role at the Netherlands Cancer Institute (NKI), Haanen is a professor at Leiden University Medical Center (LUMC) and head of the Melanoma Clinic at the Centre Hospitalier Universitaire Vaudois - CHUV in Lausanne, Switzerland. Haanen will receive the award during the opening ceremony of the ESMO Congress 2024 on September 13. Congratulations, John Haanen, on this well-deserved recognition! 🎉 #esmo24 #cancerresearch #nki #TIL #immunotherapy
Congrats John, well deserved
Ditto for me! Congrats John on being recognized for a long list of accomplishments and for being a real “stand up” guy.
Congratulations with this great achievement
Congratulations and Best Wishes
Proficiat John en welverdiend voor je fantastische werk!
What a wonderful honor- congrats, John!!!
Congratulations! Great achievement! 🎉
Congratulations!!!
Strategist for Vision Zero Cancer- mission-driven innovation in cancer
2moCongratulations, John, this is fantastic and so well-deserved 👏 👏 👏 . Even if we don't always agree on trial designs 😝 - thank you for what you have done and continue to do for us in #Melanoma.